Sort by
Refine Your Search
-
Posting Details Position Details Title Postdoctoral Position: Neuroendocrine Mechanisms of Aggressive Behavior Appointment Status Non-Tenure Track Department IU Bloomington Biology Location
-
Minimum Qualifications: · PhD in Immunology, Cancer Biology, Biomedical Engineering, or a related discipline · Demonstrated experience in mouse handling and tumor models or nanomedicine/biomedical
-
of quantum algorithms for hybrid quantum simulators. Applicants should have a PhD in Physics, Chemistry, Computer Science, or a closely related field. To apply, a CV, a brief statement of research interests
-
-brain barrier research. Ideal candidates will have: 1.A PhD in the life sciences 2.A solid background in cell culture and tissue engineering approaches 3.Knowledge in Neuroscience and Stem Cell Research 4
-
. Applications will be accepted until the position is filled. Basic Qualifications Doctorate or terminal degree required Department Contact for Questions Will Report to: Alex P. Miller, PhD Assistant Professor
-
funded by the National Institutes of Health. The current lab research is focused on the pathogenesis and molecular mechanism of diabetes and obesity, fatty liver disease, and cancer using both cell systems
-
Posting Details Position Details Title Postdoctoral Researcher Appointment Status Non-Tenure Track Department IU Indianapolis Department of Biomedical Engineering and Informatics – Luddy School
-
Postdoctoral Researcher – AI-Augmented Decision Science Indiana University Bloomington Department of Psychological & Brain Sciences and Luddy School of Informatics, Computing, & Engineering Position Overview
-
Postdoctoral Researcher – AI-Augmented Decision Science Indiana University Bloomington Department of Psychological & Brain Sciences and Luddy School of Informatics, Computing, & Engineering Position Overview
-
research on pediatric brain tumors, primarily pineoblastoma. Our research is focused on examining the molecular mechanisms of tumor progression and the identification of novel drug targets using genomic and